If limiting the risk of hypoglycemia is a priority when optimizing glycemic management in patients with type 2 diabetes who are using only metformin, clinicians should consider adding a GLP-1 RA such as liraglutide, which has a low likelihood of hypoglycemia and high efficacy of glucose lowering [8]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.